Related Experiment Video
Updated: May 24, 2026

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
Published on: January 7, 2019
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff1, Amit U Sinha, Michael J Kluk
1Dana-Farber/Children's Hospital Cancer Center, Boston, MA 02115, USA.
Polycomb repressive complex 2 (PRC2) plays a role in acute myeloid leukemia (AML) progression. While not essential for initial leukemia growth, inhibiting Ezh2 impacts AML progression and gene expression, suggesting therapeutic potential.
Area of Science:
- Epigenetics
- Cancer Biology
- Hematology
Background:
- Epigenetic mechanisms, including Polycomb repressive complex 2 (PRC2), are increasingly recognized for their role in cancer.
- PRC2 components are overexpressed in many cancers, but their precise function in cancer development and progression is not fully understood.
Purpose of the Study:
- To investigate the role of PRC2 function in leukemia development and progression using conditional alleles for enhancer of zeste 2 (Ezh2) and embryonic ectoderm development (Eed).
Main Methods:
- Conditional knockout alleles for Ezh2 and Eed were used in MLL-AF9-mediated acute myeloid leukemia (AML) models.
- Leukemia progression was assessed via secondary transplantation assays.
- Genome-wide analyses of H3K27me3 and gene expression arrays were performed.
Main Results:
- Ezh2-null AML showed impaired acceleration upon secondary transplantation but retained self-renewal capacity.
- Partial compensation of Ezh2 loss by Ezh1 was observed, indicated by locus-specific H3K27me3 persistence.
- Inactivation of Eed led to complete PRC2 loss and was incompatible with leukemia growth, causing more profound gene expression changes than Ezh2 inactivation.
Conclusions:
- Ezh2 is not strictly required for MLL-AF9 AML initiation but contributes to leukemia progression.
- Eed is essential for PRC2 function and leukemia viability.
- Targeting PRC2 function presents a potential therapeutic strategy for AML.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Anaphase Promoting Complex
Differentiation of Common Myeloid Progenitor Cells
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

